Clinical Trial Update: A Study of Camrelizumab Combined With Chemotherapy ± Thalidomide in First-line Treatment of Patients With Advanced Non-small Cell Lung Cancer (NSCLC) [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating camrelizumab in combination with chemotherapy with or without thalidomide as first-line treatment for advanced non-small cell lung ca…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Camrelizumab (camrelizumab)

Snippet

Sponsor: Tongji University | Conditions: Lung Cancer, Camrelizumab | Phase 4 | Status: NOT_YET_RECRUITING